In a Lima pharmacy, the owner’s phone is the new distributor. OpenMed, a startup founded in 2022, has built a B2B marketplace on that screen. Its mobile app offers independent pharmacies, known locally as boticas, a digital catalog of over 2,500 pharmaceutical products for direct ordering [Infomercado, April 2023]. The bet is simple: replace a phone-and-paper supply chain with a single, verified digital channel.
The Wedge in the Supply Chain
The company’s wedge is the independent pharmacy, a critical but often underserved node in Latin America’s healthcare network. These small businesses face operational friction: calling multiple distributors, managing paper invoices, and tying up capital in inventory. OpenMed’s platform, with data verified by health professionals, consolidates access to laboratories and wholesalers [OpenMed - made with Wegic, Unknown]. The goal is to reduce the time, cost, and effort for a botica to stock its shelves, positioning the startup as an end-to-end procurement and distribution layer rather than a simple listing service [Infomercado, April 2023].
The Team Building the Channel
Five co-founders are steering the venture from Peru. Angelo Vásquez serves as CEO, with Harold Gutiérrez as CTO, Renzo Rosas as CPO, Karina Flores leading UX/UI, and Julio Kauss as a co-founder [Infomercado, April 2023]. The team’s public profiles suggest a technical and product-focused build, with Gutiérrez listing experience as a cloud and full-stack developer [Harold Gutierrez - Auxiliar administrativo en Fleet Complete, Unknown]. Their collective aim, per Vásquez’s LinkedIn, is to build a more reliable healthcare system [Angelo Vasquez Flexer - LinkedIn, Unknown].
| Role | Name |
|---|---|
| CEO & Co-Founder | Angelo Vásquez |
| CTO & Co-Founder | Harold Gutiérrez |
| CPO & Co-Founder | Renzo Rosas |
| Head of UX/UI & Co-Founder | Karina Flores |
| Co-Founder | Julio Kauss |
| Table: OpenMed's founding team as reported in 2023 [Infomercado, April 2023]. |
The Scale of the Ambition
The potential market is vast, if the model proves out. The company cites a Latin American consumer base of over 662 million people and a specific aim to serve more than 150 million people with chronic diseases [Infomercado, April 2023] [Openmed.pe, Unknown]. Success hinges on capturing a meaningful share of Peru’s fragmented pharmacy market first, then replicating the playbook. The value proposition for labs is equally clear: a streamlined digital sales channel to thousands of small outlets that are otherwise costly to reach directly.
The Road Ahead and Its Hurdles
The path from a launched app to a scaled marketplace is rarely smooth. The company operates in a capital-intensive sector, connecting physical goods between businesses, yet no external funding rounds or named investors are visible in the public record. This suggests a bootstrapped or very early-stage venture, which raises questions about its war chest for sales, marketing, and inventory financing. Furthermore, it is not the only player eyeing this space. Colombian competitor Farmalisto has also targeted pharmacy digitization, creating a competitive landscape that will test OpenMed’s product differentiation and execution speed.
The primary risks for a venture at this stage are clear:
- Capital runway. Building liquidity in a two-sided marketplace requires significant capital to attract and retain both suppliers and buyers. The absence of disclosed funding is a notable gap.
- Supplier density. A catalog of 2,500 products is a start, but pharmacy owners need comprehensive, reliable stock. Securing exclusive or preferred agreements with major labs will be critical.
- Operational grit. Logistics, payments, and customer support in pharmaceuticals are heavily regulated. Scaling these operations across borders adds layers of complexity.
The venture’s next milestones are straightforward: prove repeat purchase velocity among its initial pharmacy cohort, secure its first institutional capital to fuel growth, and expand its supplier network. For now, the OpenMed team is focused on a single, tangible metric: how many independent pharmacies in Peru can run their procurement entirely through a phone. The question for any watcher of Latin American fintech and logistics is whether that focus is enough to attract the check needed to move from a promising app to a regional platform.
Sources
- [Infomercado, April 2023] OpenMed la startup que busca convertirse en el principal Marketplace B2B de la industria farmacéutica | https://www.infomercado.pe/openmed-la-startup-que-busca-convertirse-en-el-principal-marketplace-b2b-de-la-industria-farmaceutica/
- [OpenMed - made with Wegic, Unknown] OpenMed platform description | https://openmed.com.vn/
- [Harold Gutierrez - Auxiliar administrativo en Fleet Complete, Unknown] Harold Gutierrez LinkedIn profile | https://www.linkedin.com/in/harold-gutierrez-39b9801b0/
- [Angelo Vasquez Flexer - LinkedIn, Unknown] Angelo Vasquez Flexer LinkedIn profile | https://www.linkedin.com/in/angelo-vasquez-flexer/
- [Openmed.pe, Unknown] OpenMed company description | https://openmed.pe/